T. Taishi

发表

Carbamoyl pyridone HIV-1 integrase inhibitors. 1. Molecular design and establishment of an advanced two-metal binding pharmacophore.

T. Seki, T. Fujiwara, T. Yoshinaga, 2012, Journal of medicinal chemistry.

Carbamoyl pyridone HIV-1 integrase inhibitors. 2. Bi- and tricyclic derivatives result in superior antiviral and pharmacokinetic profiles.

E. Garvey, T. Seki, T. Fujiwara, 2013, Journal of medicinal chemistry.

Total Synthesis of Terprenin, a Novel Immunosuppressive p-Terphenyl Derivative.

T. Nakatani, K. Kawada, S. Yonezawa, 1998, The Journal of organic chemistry.

FIRST TOTAL SYNTHESIS OF ()-STACHYFLIN

T. Taishi, S. Takechi, S. Mori, 1998 .

Total Synthesis of Terprenin, a Highly Potent and Novel Immunoglobulin E Antibody Suppressant.

T. Nakatani, K. Kawada, S. Yonezawa, 1998, Angewandte Chemie.

In Vitro Antiretroviral Properties of S/GSK1349572, a Next-Generation HIV Integrase Inhibitor

Shigeru Miki, Akihiko Sato, Kevin W. Brown, 2010, Antimicrobial Agents and Chemotherapy.

Antiviral Characteristics of GSK1265744, an HIV Integrase Inhibitor Dosed Orally or by Long-Acting Injection

E. Garvey, T. Seki, T. Fujiwara, 2014, Antimicrobial Agents and Chemotherapy.

First Total Synthesis of (.+‐.)‐Stachyflin.

T. Taishi, S. Takechi, S. Mori, 1998 .

Carbamoyl pyridone HIV-1 integrase inhibitors 3. A diastereomeric approach to chiral nonracemic tricyclic ring systems and the discovery of dolutegravir (S/GSK1349572) and (S/GSK1265744).

E. Garvey, T. Seki, S. Foster, 2013, Journal of medicinal chemistry.

Access to an optically pure key intermediate of dihydromevinolin

K. Kanematsu, T. Taishi, S. Nagashima, 1994 .